Skip to Main content Skip to Navigation
Journal articles

Topical rapamycin (sirolimus) for treatment of cutaneous microcystic lymphatic malformation of the gluteal area

Abstract : Cutaneous microcystic lymphatic malformations (CMLMs) are rare conditions that result from abnormal embryological development of lymphatic vessels [1]. They present as clusters of vesicles that are full of lymph and blood. CMLMs commonly affect the lower limbs, gluteal areas, or the head and neck. The most frequent complications are oozing, bleeding, aesthetic impairment, pain, or bacterial infections. The management is challenging. Treatment options include surgery, laser therapy
Complete list of metadata

https://hal.inrae.fr/hal-02619966
Contributor : Migration Prodinra <>
Submitted on : Monday, May 25, 2020 - 9:09:59 PM
Last modification on : Thursday, May 6, 2021 - 2:21:47 PM

Identifiers

Collections

Citation

Sophie Leducq, Sandy Vrignaud, Gérard Lorette, Denis Herbreteau, Vincent Dubée, et al.. Topical rapamycin (sirolimus) for treatment of cutaneous microcystic lymphatic malformation of the gluteal area. European Journal of Dermatology, John Libbey Eurotext, 2019, 29 (1), pp.82-83. ⟨10.1684/ejd.2018.3440⟩. ⟨hal-02619966⟩

Share

Metrics

Record views

30